Serum SIL-2R, TNF-alpha and IFN-gamma in Alveolar Echinococcosis
Overview
Affiliations
Aim: to approach the relationship between alveolar echinococcosis (AE) pathology and level of sIL-2R,TNF-alpha and IFN-gamma in sera and the significance of cytokines in development of AE.
Methods: After 23 patients with AE were confirmed by ELISA and ultrasound, their sera were collected and the concentrations of sIL-2R,TNF-alpha and IFN-gamma were detected by double antibody sandwich. Twelve healthy adults served as controls. According to the status of livers of AE patients by ultrasound scanning, they were divided into 4 groups: P(2), P(3), P(4) groups and C group (control). Average of concentrations of sIL-2R,TNF-alpha and IFN-gamma in homologous group was statistically analyzed by both ANOV and Newman-Keuls, respectively.
Results: The mean of sIL-2R in P(2) group was 97+/-29, P(3): 226+/-80, P(4): 194+/-23 and control group (111+/-30)X10(3) u/L (P<0.01). The mean of TNF-alpha in P(2) group was 1.12+/-0.20, P(3): 3.67+/-1.96, P(4): 1.30+/-0.25 and control group 0.40+/-0.19 mug/L (P<0.01). The mean of IFN-gamma in P(2) group was 360+/-20, P(3): 486+/-15, P(4): 259+/-19 and control group: 16+/-2 ng/L (P<0.01). Judged by ANOV and Newman-Keuls, the mean concentrations of sIL-2R, TNF-alpha and IFN-gamma had a significant difference among groups. Except for P(2) group, the mean sIL-2R between other groups of AE patients had a significant difference (P<0.05). The mean of TNF-alpha concentration in P(3) group was the highest (P<0.01). The mean of IFN-gamma concentration in all patients was higher than that in control group (P<0.01), but there was no difference between AE groups (P>0.05).
Conclusion: Low sIL-2R level indicates an early stage of AE or stable status, per contra, a progression stage. Higher level of TNF-alpha might be related to the lesion of liver. The role of single IFN-gamma is limited in immunological defense against AE and it can not fully block pathological progression.
Design of a novel EmTSP-3 and EmTIP based multi-epitope vaccine against infection.
Fan Y, He Y, Li Y, Yin Z, Shi J, Tian T Front Immunol. 2024; 15:1425603.
PMID: 39351224 PMC: 11439721. DOI: 10.3389/fimmu.2024.1425603.
Yarahmadov T, Wang J, Sanchez-Taltavull D, Alvarez Rojas C, Brodie T, Buchi I Infect Immun. 2022; 90(8):e0017422.
PMID: 35862712 PMC: 9387288. DOI: 10.1128/iai.00174-22.
Evaluation of Allicin Against Alveolar Echinococcosis In Vitro and in a Mouse Model.
Liu C, Fan H, Guan L, Ma L, Ge R Acta Parasitol. 2021; 67(1):79-93.
PMID: 34143400 PMC: 8938363. DOI: 10.1007/s11686-021-00434-z.
The correlations between Th1 and Th2 cytokines in human alveolar echinococcosis.
Ma X, Zhang X, Liu J, Liu Y, Zhao C, Cai H BMC Infect Dis. 2020; 20(1):414.
PMID: 32539714 PMC: 7294603. DOI: 10.1186/s12879-020-05135-y.
Abulizi A, Shao Y, Aji T, Li Z, Zhang C, Aini A BMC Infect Dis. 2019; 19(1):792.
PMID: 31500589 PMC: 6734356. DOI: 10.1186/s12879-019-4417-1.